The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

3 Mar 2023 09:53

RNS Number : 8525R
Maven Income and Growth VCT 3 PLC
03 March 2023
 

Maven Income and Growth VCT 3 PLC (the Company)

 

Issue of Equity

 

On 7 October 2022, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £5 million, with an over-allotment facility for up to a further £5 million (the Offer).

 

Pursuant to the Offer, a total of £4,641,849 of valid applications have been received in the period from 7 October 2022 up to close of business on 28 February 2023. In respect of the 2022/2023 tax year, £3,705,357 of valid applications were received in the period from 7 October 2022 up to 9.00am on 6 February 2023 and the Company issued and allotted 6,389,151 new Ordinary Shares on 8 February 2023. In the period from 6 February 2023 to close of business on 28 February 2023, in respect of the 2022/2023 tax year, £581,022 of valid applications were received, and, as a result, the Company has issued and allotted 982,796 new Ordinary Shares on 3 March 2023. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which these shares were issued were in the range of 57.90p to 58.84p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 111,264,823. Therefore, the total number of voting rights in the Company is 111,264,823.

 

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective and dealings will commence on or around 7 March 2023.

 

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Board of the Company intends that a final allotment in respect of applications for the 2022/2023 tax year will take place on or before 5 April 2023. It is also intended that an allotment in respect of applications for the 2023/2024 tax year will take place on or before 31 May 2023, unless the Offer is fully subscribed by an earlier date or extended, at the Board's discretion, to a date up to and including 6 October 2023.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

3 March 2023

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFEAVIIVIIV
Date   Source Headline
25th Aug 20172:29 pmRNSHalf-year Report
10th Aug 20174:31 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
10th Jul 201710:56 amRNSNet Asset Value(s)
15th Jun 20174:00 pmRNSDividend Declaration
12th May 20174:13 pmRNSTransaction in Own Shares
12th May 20174:07 pmRNSNet Asset Value(s)
11th May 20172:39 pmRNSTransaction in Own Shares
10th May 201712:33 pmRNSTransaction in Own Shares
28th Apr 20173:36 pmRNSDirectorate Change
27th Apr 20171:01 pmRNSNet Asset Value(s)
27th Apr 201712:57 pmRNSResult of AGM
24th Mar 20175:33 pmRNSAnnual Financial Report
26th Jan 20177:00 amRNSNet Asset Value and Proposed Final Dividend
20th Jan 201710:12 amRNSDirectorate Change
8th Nov 20164:49 pmRNSTransaction in Own Shares
7th Nov 201611:00 amRNSDirector/PDMR Shareholding
28th Oct 20168:39 amRNSNet Asset Value(s)
26th Aug 20164:36 pmRNSTransaction in Own Shares
21st Jul 20164:53 pmRNSHalf-year Report
13th Apr 20161:14 pmRNSDirectorate Change
13th Apr 20161:08 pmRNSResult of AGM
13th Apr 201612:52 pmRNSNet Asset Value(s)
11th Mar 20167:00 amRNSAnnual Financial Report
1st Mar 20164:14 pmRNSDirector/PDMR Shareholding
17th Feb 20165:02 pmRNSTransaction in Own Shares
10th Feb 20163:39 pmRNSForm 8.3 - Tangent Communications PLC
9th Feb 20164:41 pmRNSTransaction in Own Shares
8th Feb 201612:30 pmRNSTransaction in Own Shares
4th Feb 201610:48 amRNSTransaction in Own Shares
28th Jan 20162:47 pmRNSNet Asset Value & Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
30th Nov 201512:36 pmRNSTransaction in Own Shares
23rd Oct 201512:04 pmRNSNet Asset Value(s)
4th Sep 201510:51 amRNSPortfolio Update
24th Aug 20153:37 pmRNSStatement re Dividend Investment Scheme
10th Jul 20155:07 pmRNSHalf Yearly Report
15th Jun 20155:09 pmRNSDirector/PDMR Shareholding
12th Jun 201510:00 amRNSIssue of Equity
5th Jun 20153:17 pmRNSNet Asset Value(s)
27th May 20155:18 pmRNSTransaction in Own Shares
30th Apr 201512:43 pmRNSTransaction in Own Shares
29th Apr 20153:44 pmRNSTransaction in Own Shares
22nd Apr 20153:11 pmRNSTransaction in Own Shares
21st Apr 20153:45 pmRNSTransaction in Own Shares
16th Apr 20154:17 pmRNSNet Asset Value(s)
15th Apr 20153:16 pmRNSDirectorate Change
15th Apr 20153:13 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.